Literature DB >> 22262140

A fatal case of cytomegalovirus ventriculoencephalitis in a mycosis fungoides patient who received multiple umbilical cord blood cell transplantations.

Toshihiro Matsukawa1, Hideki Goto, Kenta Takahashi, Shinsuke Asanuma, Atsushi Yasumoto, Mutsumi Takahata, Akio Shigematsu, Tomoyuki Endo, Junji Tanaka, Satoshi Hashino, Shinya Tanaka, Masahiro Imamura.   

Abstract

Cytomegalovirus (CMV) infection is latent in the majority of adult humans. The reactivation of CMV causes pneumonia and gastrointestinal disease in severely immunosuppressed patients, who consequently suffer very high mortality due to CMV central nervous system disease. We report here a case involving a 28-year-old female patient with mycosis fungoides who underwent umbilical cord blood transplantation three times and developed CMV ventriculoencephalitis. The patient's CMV viremia was successfully preempted with ganciclovir (GCV) as indicated by undetectable CMV antigenemia; despite this successful treatment, the patient developed CMV ventriculoencephalitis. Foscarnet (FCV) therapy led to a temporary recovery, after which CMV ventriculoencephalitis recurred, and the patient died after receiving combination GCV and FCV therapy. Autopsy samples revealed CMV ventriculoencephalitis, as indicated by numerous inclusion-bearing cells (Owl's eye). It is likely that this patient harbored a GCV-resistant CMV strain; however, it was not possible to obtain nucleic acids suitable for use in assessing this possibility.

Entities:  

Mesh:

Year:  2012        PMID: 22262140     DOI: 10.1007/s12185-012-1003-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  28 in total

1.  NeuroImages. "Owl's eyes" of CMV ventriculitis.

Authors:  D I Rubin
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

2.  Cellular therapy with sequential unmanipulated donor lymphocyte infusions in drug-resistant cytomegalovirus (CMV) encephalitis.

Authors:  Gorgun Akpek; Maria Mikulski; Michael Kleinberg; Ashraf Badros; Saul Yanovich; Aaron P Rapoport
Journal:  Blood       Date:  2011-05-26       Impact factor: 22.113

3.  Cytomegalovirus ventriculoencephalitis in a reduced- intensity conditioning cord blood transplant recipient.

Authors:  T Ando; N Mitani; K Yamashita; T Takahashi; E Ohama; H Miyata; T Yujiri; Y Tanizawa
Journal:  Transpl Infect Dis       Date:  2010-10       Impact factor: 2.228

4.  Human cytomegalovirus latent infection of granulocyte-macrophage progenitors.

Authors:  K Kondo; H Kaneshima; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

5.  Human pharmacokinetics of the antiviral drug DHPG.

Authors:  C Fletcher; R Sawchuk; B Chinnock; P de Miranda; H H Balfour
Journal:  Clin Pharmacol Ther       Date:  1986-09       Impact factor: 6.875

Review 6.  Antiviral drug resistance of human cytomegalovirus.

Authors:  Nell S Lurain; Sunwen Chou
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Penetration of foscarnet into cerebrospinal fluid of AIDS patients.

Authors:  F Raffi; A M Taburet; B Ghaleh; A Huart; E Singlas
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation.

Authors:  R Zeiser; C Grüllich; H Bertz; G Pantazis; F T Hufert; T A Bley; J Finke
Journal:  Bone Marrow Transplant       Date:  2004-01       Impact factor: 5.483

9.  Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet.

Authors:  Petr Hubacek; Petra Keslova; Renata Formankova; Pavel Pochop; Ondrej Cinek; Miroslav Zajac; Jana Lochmanova; Jan Stary; Petr Sedlacek
Journal:  Pediatr Transplant       Date:  2008-11-01

10.  Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation.

Authors:  Suzanne O Arulogun; H Miles Prince; Jonathan Ng; Stephen Lade; Gail F Ryan; Odette Blewitt; Christopher McCormack
Journal:  Blood       Date:  2008-07-22       Impact factor: 22.113

View more
  2 in total

1.  Cytomegalovirus Encephalitis in a Patient with Severe Combined Immunodeficiency.

Authors:  Mitsuo Motobayashi; Tomonari Shigemura; Miyuki Tanaka; Takashi Kurata; Norimoto Kobayashi; Kazunaga Agematsu; Yoshiro Amano; Yuji Inaba; Kenichi Koike; Yozo Nakazawa
Journal:  J Clin Immunol       Date:  2015-11-07       Impact factor: 8.317

2.  Proceedings of the 2013 Joint JSTP/NTP Satellite Symposium.

Authors:  Susan A Elmore; Mark Hoenerhoff; Osamu Katsuta; Hiroko Kokoshima; Robert Maronpot; Hiroaki Nagai; Hiroshi Satoh; Yasuhiro Tanaka; Tomoaki Tochitani; Seiichiro Tsuchiya; Katsuhiko Yoshizawa
Journal:  J Toxicol Pathol       Date:  2013-07-10       Impact factor: 1.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.